Edition:
United Kingdom

Stryker Corp (SYK.N)

SYK.N on New York Stock Exchange

214.10USD
23 Aug 2019
Change (% chg)

$-4.17 (-1.91%)
Prev Close
$218.27
Open
$218.20
Day's High
$219.60
Day's Low
$212.80
Volume
391,939
Avg. Vol
299,528
52-wk High
$222.00
52-wk Low
$144.77

Summary

Name Age Since Current Position

Kevin Lobo

53 2018 Chairman of the Board, Chief Executive Officer

Timothy Scannell

54 2018 President, Chief Operating Officer

Glenn Boehnlein

57 2016 Chief Financial Officer, Vice President

Viju Menon

51 2018 Group President - Global Quality and Operations

M. Kathryn Fink

49 2016 Chief Human Resource Officer, Vice President

Bijoy Sagar

50 2018 Chief Digital Technology Officer, Vice President

William Berry

53 2014 Principal Accounting Officer, Vice President, Corporate Controller

Yin Becker

55 2016 Vice President - Communications, Public Affairs and Corporate Marketing

Katherine Owen

48 2007 Vice President - Strategy and Investor Relations

Robert Fletcher

2019 Vice President, Chief Legal Officer

Michael Hutchinson

48 2019 Vice President

Allan Golston

52 2018 Lead Independent Director

Mary Brainerd

65 2017 Independent Director

Srikant Datar

65 2009 Independent Director

Roch Doliveux

63 2010 Independent Director

Louise Francesconi

65 2006 Independent Director

Sherilyn McCoy

60 Independent Director

Andrew Silvernail

48 2013 Independent Director

Ronda Stryker

64 1984 Independent Director

Rajeev Suri

52 Independent Director

Biographies

Name Description

Kevin Lobo

Mr. Kevin A. Lobo is Chairman of the Board, Chief Executive Officer of the Company. He was named Chairman of the Board in July 2014 and has served as Chief Executive Officer of the Company since 2012. He joined the Company as a Group President in April 2011. Prior thereto, he held leadership roles over eight years with Johnson & Johnson, including president of Ethicon Endo-Surgery. Mr. Lobo is also a director of Parker-Hannifin Corporation, a manufacturer of motion and control technologies and systems. Mr. Lobo's global business and leadership experience across multiple industries, including healthcare, enables him to provide valuable insight to the Board regarding the Company's operations and the strategic planning initiatives necessary to meet the demands of the changing environment. As the sole member of management on our Board, he provides management's business perspectives and the necessary link to the Company's day-to-day operations.

Timothy Scannell

Mr. Timothy J. Scannell is President, Chief Operating Officer of the Company effective August 1, 2018. He began his career with Stryker in 1990 with our Endoscopy division, where he served in various sales and marketing leadership roles. Mr. Scannell progressed to the position of Executive Vice President, overseeing sales, marketing and operations. In 2001, he was appointed Vice President and General Manager of our Biotech division. In 2003, he was named Vice President and General Manager of our Spine division and was later promoted to President of Spine. In 2009, he was appointed to the position of Group President and initially was responsible for the Spine and Endoscopy divisions. Over time, the role expanded to include MedSurg and Neurotechnology, with each of the group’s divisional leaders reporting to him. He serves on the Board of Directors for Insulet Corporation, whose OmniPod®Insulin Management System helps to improve the lives of people with diabetes.

Glenn Boehnlein

Mr. Glenn S. Boehnlein is Chief Financial Officer, Vice President of the Company. He has global responsibilities for Finance activities, including Corporate Accounting, Reporting, Tax, Treasury and Internal Audit. Mr. Boehnlein began his career with us in 2003 as the Vice President of Finance and IT for our Endoscopy division and has taken on roles of increasing responsibility throughout his career, most recently as Group CFO of MedSurg and Neurotechnology. Prior to joining us, Mr. Boehnlein spent three years with Success TV as CFO. Prior to that, he was a partner and certified public accountant at Arthur Andersen. He received his bachelor’s and master’s degrees in accounting from Mississippi State University.

Viju Menon

Mr. Viju Menon is Group President - Global Quality and Operations of the Company. He is responsible for leading regulatory and quality, global supply, manufacturing and direct procurement, and supply chain operations including logistics and integrated business planning. Prior to joining us, Mr. Menon held various senior supply chain leadership roles and served as the Chief Supply Chain Officer and Senior Vice President at Verizon. Before his work at Verizon, Mr. Menon held key leadership roles at Intel Corporation in technology and manufacturing. Mr. Menon earned dual graduate degrees (MBA and M.S. in Electrical Engineering) from the Massachusetts Institute of Technology's Leaders for Global Operations Program. He also earned a graduate degree (M.S.E. in Computer Science Engineering) from the University of Michigan.

M. Kathryn Fink

Ms. M. Kathryn (Katy) Fink is Chief Human Resource Officer, Vice President of the Company. She is responsible for all human resources policies, practices, planning, direction and activities, including Talent Acquisition, Talent Development, Total Rewards and HR Shared Services. Ms. Fink began her career with us in 2013 as Vice President, Talent Management and became Vice President, Human Resources, MedSurg and Neurotechnology Group in 2015. Prior to joining us, she held a number of HR roles of increasing scope and complexity at Cintas Corporation and Ethicon Endo-Surgery, a division of Johnson & Johnson. Ms. Fink holds a Bachelor of Science degree from Kenyon College and Master's degree in human resource management (HRM) from Rutgers' School of Management and Labor Relations.

Bijoy Sagar

Mr. Bijoy S.N. Sagar is Chief Digital Technology Officer, Vice President of the Company. He is responsible for the development and execution of our digital strategy as well as our global information technology strategy. His function helps build digital services for our customers and solutions that enable excellent customer experience. He joined Stryker as Vice President, Chief Information Officer in May 2014. Prior to joining us, Mr. Sagar spent 20 years in the medical technology industry, most recently serving as Chief Information Officer for Merck Millipore, and before that as Global Head of Information Systems and a member of the Divisional Board for the $15 billion Chemicals division of Merck KGaA. Prior to joining Merck in 2006, Bijoy held various roles of increasing responsibility with Millennium Pharmaceuticals, Amgen and Eli Lilly & Company.

William Berry

Mr. William E. Berry Jr., is Principal Accounting Officer, Vice President, Corporate Controller of the Company. He has oversight responsibility for the global accounting and financial functions and is responsible for internal reporting and consolidations, SEC and external reporting, financial accounting research, policies and procedures and our finance training and development programs. Mr. Berry joined us in August 2011 as Corporate Controller. Prior to that, he served as the Assistant Corporate Controller for Whirlpool Corporation, the world’s leading global manufacturer and marketer of major home appliances, leading the accounting and reporting functions for the multi-national company. From 2007 to 2009 Mr. Berry served as the Controller of the Electronics and Safety Division of Delphi Automotive LLP, a leading global vehicle components manufacturer. From 1995 to 2007 Mr. Berry served Federal-Mogul Corporation, a leading global supplier of vehicle and industrial products, and during his 12-year tenure he held various positions of increasing responsibility, most recently as the Director of Finance for Global Powertrain and prior to that, while based in Germany, as the Director of Corporate Finance for Europe and South Africa.

Yin Becker

Ms. Yin C. Becker is Vice President - Communications, Public Affairs and Corporate Marketing of the Company. She leads the development and management of the company’s global communications, public affairs and company-level marketing strategies that enhance our position as an industry leader. With 30 years of experience in the medical technology industry, Ms. Becker’s career spans several senior leadership positions at Stryker. She served as Vice President, Healthcare Innovations, Executive Director of the Homer Stryker Learning Center and Vice President, Global Communications for our Orthopaedics business. Prior to joining us, Ms. Becker also served for ten years at Pfizer Inc. in various leadership roles in marketing and education.

Katherine Owen

Ms. Katherine Ann Owen is Vice President - Strategy and Investor Relations of the Company. She is responsible for overseeing the strategic planning and business development processes at Stryker, as well as investor relations. Prior to joining us, Ms. Owen served as a Medical Technology Analyst at Merrill Lynch. She previously served as a Medical Technology Analyst at Cowen & Co./SG Cowen. She also was a Corporate Lending Analyst at State Street Bank and an Underwriter at Chubb Insurance Corporation.

Robert Fletcher

Michael Hutchinson

Allan Golston

Mr. Allan C. Golston is Lead Independent Director of the Company. He is a President, United States Program for the Bill & Melinda Gates Foundation since 2006, and Chief Financial and Administrative Officer of the Bill & Melinda Gates Foundation from 2000 to 2006. Mr. Golston is also a director of Harley-Davidson, Inc., a manufacturer of motorcycles and accessories. Mr. Golston has extensive experience in auditing, finance and the healthcare industry. He is a Certified Public Accountant and has held positions as a finance executive with Swedish Health Services (Seattle, WA) and the University of Colorado Hospital. In his service to the Gates Foundation, he has contributed to the strategic formation and operation of successful initiatives to provide healthcare, education and other human needs, all of which give him understanding that will assist Stryker in our global efforts to meet the needs of patients and caregivers. Additionally, Mr. Golston's expertise in financial matters enables him to make valuable contributions to our Audit Committee and his overall experience positions him well to serve as our Lead Independent Director.

Mary Brainerd

Ms. Mary K. Brainerd is Independent Director of the company. She is a former President and Chief Executive Officer of HealthPartners, the largest, consumer-governed, nonprofit health care organization in the United States, which she led from 2002 to May 2017. Prior to joining HealthPartners in 1992, she held various executive roles with Blue Cross and Blue Shield of Minnesota from 1984 to 1992. She also serves as a director of Bremer Bank and Securian Financial, a financial services company headquartered in Minneapolis. Ms. Brainerd’s extensive experience surrounding both health care delivery and insurance enable her to provide unique and invaluable insight to our Board discussions, particularly in light of the evolving landscape in the health care delivery and payer markets.

Srikant Datar

Dr. Srikant M. Datar, Ph.D., is Independent Director of the Company. Arthur Lowes Dickinson Professor at the Graduate School of Business Administration of Harvard University since 1996. Faculty Chair of the Harvard Innovation Labs and Senior Associate Dean for University Affairs. From 1989 to 1996, he was Edmund W. Littlefield Professor at the Graduate School of Business, Stanford University. Dr. Datar is also a director of Novartis AG, a multinational pharmaceutical and consumer health products company, ICF International, Inc., a management, technology and policy consulting firm, and T-Mobile US, Inc., a provider of wireless voice, messaging and data services. Dr. Datar has an extensive background in accounting and finance and a variety of other business areas, including organization design and performance measurement. His strong academic and business background and his experience on the board committees of other companies allow him to make significant contributions to our committees. His service on the boards of global companies involved in pharmaceuticals and high tech gives him great insights into assessing the Company's technology and strategies to expand our business globally.

Roch Doliveux

Dr. Roch Doliveux, DVM, is Independent Director of the Company, since June 21, 2010. He is a Chairman of the Board, Pierre Fabre SA, a global dermocosmetics and healthcare company. Chairman of GLG Institute, a community of senior executives for experience sharing and learning. Director of UCB, a global biopharmaceutical company, where he was Chief Executive Officer for 10 years. He is also Chairman of the Board of the Vlerick Business School, a top-100 business school in the world based in Belgium and of the Caring Entrepreneurship Fund, a philanthropic organization to help entrepreneurs start their own businesses in healthcare. Dr. Doliveux has extensive experience in life science and healthcare companies, including research, development, regulatory, medical, marketing, market access, sales and M&A, as well as strategic and organizational change management. His exposure to business in many geographies and cultures is very valuable as Stryker seeks to expand its global presence.

Louise Francesconi

Ms. Louise L. Francesconi is Independent Director of the Company, since July 26, 2006. She is a Former Vice President of Raytheon Company and former President of Raytheon Missile Systems, which she led from 1996 to July 2008. She is Chairman of the Tucson Medical Center Healthcare Board of Trustees and a director of UNS Energy Corporation, a utility that delivers natural gas and electric service. Ms. Francesconi's extensive experience in various leadership roles in operations and finance functions at Raytheon and other major businesses for over 30 years enable her to bring a wealth of insight into the complex operational, financial and governance issues facing the Company. Her role as Chairman of the Tucson Medical Center Board also has provided useful insights from the perspective of a healthcare provider.

Sherilyn McCoy

Ms. Sherilyn S. McCoy is Independent Director of the Company. She was Former Chief Executive Officer and Director of Avon Products, Inc., a personal care products company, which she led for almost six years until she retired in February 2018. Prior thereto, Ms. McCoy had a 30-year career at Johnson & Johnson, where she led a variety of large medical device, pharmaceutical and consumer businesses and rose to the position of Vice Chair. She is also a director of AstraZeneca plc, a global, science-led biopharmaceutical company; Kimberly-Clark, a multinational manufacturer of personal care products; and Novacure, an oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields. Ms. McCoy has deep global experience as well as strong knowledge regarding mergers and acquisitions and the management of complex organizational structures. These skills, along with her background in the medical technology industry and extensive experience in a public company environment, enable her to bring valuable insights to our Board.

Andrew Silvernail

Mr. Andrew K. Silvernail is Independent Director of the company. He is a Chairman, President and Chief Executive Officer of IDEX Corporation, an applied solutions business serving high growth specialized markets, Chairman since 2012 and President and Chief Executive Officer since 2011, and Vice President, Group Executive from January 2009 to August 2011. Mr. Silvernail is also a trustee for the Manufacturers Alliance for Productivity and Innovation (MAPI) and serves on the Board of Advisors for the Thayer School of Engineering at Dartmouth College. By virtue of his service as Chairman, President and Chief Executive Officer of IDEX Corporation and his prior experience in executive leadership positions with IDEX and another large public company, Mr. Silvernail provides valuable business, leadership and management insights and useful perspectives to our Board discussions. His experience leading a large public company with global operations gives him a clear understanding of the issues facing a multinational business such as ours.

Ronda Stryker

Ms. Ronda E. Stryker is Independent Director of Stryker Corp. She is a Granddaughter of the founder of the Company and daughter of a former President of the Company. She is also Vice Chair and a director of Greenleaf Trust, a Michigan chartered bank, Vice Chair of Spelman College and member of the Harvard Medical School Board of Fellows. Ms. Stryker brings a strong interest in advocating the benefits of diversity and various matters regarding social responsibility. As the Company's largest individual shareholder and a member of the founding family, she brings a strong shareholder perspective, unlike that of any other member of our Board, making her a valuable component of a well-rounded Board.

Rajeev Suri

Mr. Rajeev Suri is Independent Director of the Company. He is President and Chief Executive Officer of Nokia, a leading global technology company, since April 2014. From 2009 to 2014, he was Chief Executive Officer of Nokia Solutions and Networks (previously Nokia Siemens Networks). Much of his nearly 30-year career has been spent in leadership roles at Nokia. He is also a United Nations Broadband Commissioner and a member of the steering committee of the Digital Communications Industry at the World Economic Forum. Mr. Suri has deep business experience working across a range of functions, including strategy, mergers and acquisitions, marketing and sales. He has led a transformation of Nokia through significant portfolio adjustments, including the acquisition of Alcatel-Lucent, and has strong global experience. This background and Mr. Suri’s extensive knowledge across a range of technology solutions provide critical input to our Board.